The Power of Collaboration
The founders of the Mayo Clinic in the late nineteenth century were medical practitioners who recognised the power of an alliance. In response to a medical crisis caused by a tornado, the doctors Mayo helped develop a community hospital that became the basis for the Mayo Clinic.
It was an early example of successful collaboration, bringing together colleagues considered the best in their respective fields. And it has endured to this day. As we expand as a specialty, and as we work on ever-widening fronts, it may be timely to reflect on the words of Dr William Mayo, founding brother of the Mayo Clinic: "No one is big enough to be independent of others."
As a specialty we have engaged with multidisciplinary teams which undoubtedly has contributed to improvements in patient care. However, we have also struggled to embrace collaborations that cross geographic and disciplinary boundaries. While collaborative relationships across these boundaries may be difficult to achieve, they are critical to initiating real transformative change in patient care improvements. 1 After all, it is the best patient outcomes that we are striving to achieve through our collaborative efforts. When the next implant crisis occurred -the PIP issue in 2010 -it escalated rapidly as the registry data was not of sufficient quality and reliability to mitigate against the prevailing emotional tension.
We found that we were unable to advise government and regulators because the BIR's implant capture rate was so low. 4 This was a global phenomenon, not just an Australian issue, but it did prompt a national collaborative effort to revisit the registry issue with renewed vigour. Before we could re-build this registry, we had to cross a disciplinary boundary and engage Monash University's Department of Epidemiology and Preventive Medicine. It soon became clear that we had to embrace registry principles that were counter-intuitive to Plastic Surgeons.
The new registry had to involve all practitioners involved in breast implant surgery including Plastic Surgeons, breast oncoplastic surgeons, cosmetic doctors, and others with a vested interest in breast implant surgery, including patient advocates, representatives from industry, regulatory experts from the Therapeutic Goods Administration (TGA) and personnel from the Commonwealth Department of Health. In addition, the consent process for patients was to be opt-out, the dataset to be collected was restricted to a bare minimum number of core data points, and an outcome measurement system was required to ensure this new registry qualified as a best practice Clinical Quality Registry (CQR). 5 It was true collaborative intent that made the new registry possible; the more we collaborated with this diverse range of experts, the more we learnt about other areas of knowledge, hitherto foreign to us. 6 The new Australian Breast Device Registry (ABDR) has shared the lessons learnt in its establishment with international Plastic Surgeons faced with the same challenge of building national breast implant registries. 7 However, in order to be relevant internationally, there needed to be a minimum dataset with data definitions agreed upon by international Plastic Surgeon collaborators. 8 With this in mind and with funding from the Australasian Foundation for Plastic Surgery, an International Collaboration of Breast Registry Activities (ICOBRA) was formed by reaching over geographic boundaries to collaborate with international colleagues. By doing so, we can harmonise datasets, data definitions and outcome measures to facilitate registry data pooling globally. 9 This ability to compare "like-with-like" is particularly relevant as Plastic Surgeons around the world grapple with the causative factors of implant-related anaplastic large cell lymphoma. 10 A further collaborative venture has seen the development of registry-specific Patient Reported Outcomes Measures (PROMs) derived from the BREAST-Q measurement system. 11 Without meaningful collaborations, these concepts could not have been realised.
As the specialty of Plastic Surgery advances, it is to everyone's benefit to have international connectivity. This goal is achievable through strong collaborative networks such as the newly formed International Confederation of Plastic Surgery Societies (ICOPLAST). This includes 63 countries and over 25,000 Plastic Surgeons. The purpose of ICOPLAST "is to enhance international communication, education, and advocacy processes to ultimately improve patient outcomes for Plastic Surgery patients globally." 12 ICOPLAST will also benefit Plastic Surgery as a profession, and each individual Plastic Surgeon. Australian and New Zealand Plastic Surgeons have been at the forefront of many innovations in Plastic, Reconstructive, and Aesthetic Surgery. 13 They should maintain this prominent profile on the international stage by engaging with all stakeholders to improve outcomes for all patients in their care. This mission will be realised by harnessing the power of collaboration across borders of discipline and geography, locally, nationally and internationally.
